Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial

Autor: Wise RA, Calverley PMA, Carter K, Clerisme-Beaty E, Metzdorf N, Anzueto A

Publikováno v: International Journal of COPD, Vol Volume 13, Pp 605-616 (2018)

Robert A Wise,1 Peter MA Calverley,2 Kerstine Carter,3 Emmanuelle Clerisme-Beaty,4 Norbert Metzdorf,5 Antonio Anzueto6 1Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2Respiratory Me

Externí odkaz: https://doaj.org/article/bf222838b8b643bdbe8f31511dead29f

Impact and prevention of severe exacerbations of COPD: a review of the evidence

Autor: Halpin DMG, Miravitlles M, Metzdorf N, Celli B

Publikováno v: International Journal of COPD, Vol Volume 12, Pp 2891-2908 (2017)

David MG Halpin,1 Marc Miravitlles,2 Norbert Metzdorf,3 Bartolomé Celli4 1Department of Respiratory Medicine, Royal Devon and Exeter Hospital, Exeter, UK; 2Pneumology Department, Hospital Universitari Vall d’Hebron, CIBER de Enfermedades Respirato

Externí odkaz: https://doaj.org/article/3db278f858eb4d3bb1974914aa1f309d

Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT.

Autor: Putcha N; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland., Anzueto AR; Department of Pulmonary Medicine and Critical Care, University of Texas and South Texas Veterans Health Care System, San Antonio, Texas., Calverley PMA; Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom., Celli BR; Pulmonary Division, Brigham and Women's Hospital, Boston, Massachusetts., Tashkin DP; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Metzdorf N; Respiratory Medicine, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; and., Mueller A; Biostatistics and Data Sciences Europe, Boehringer Ingelheim Pharma GmbH and Company KG, Biberach an der Riss, Germany., Wise RA; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Publikováno v: Annals of the American Thoracic Society [Ann Am Thorac Soc] 2022 Feb; Vol. 19 (2), pp. 204-213.

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.

Autor: Singh D; Division of Infection, Immunity, and Respiratory Medicine, University of Manchester, Manchester University National Health Service Hospital Trust, Manchester, United Kingdom., Bafadhel M; Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Brightling CE; Institute for Lung Health, National Institute for Health Research Leicester Biomedical Research Centre, Department of Respiratory and Infection Sciences, University of Leicester, Leicester, United Kingdom., Sciurba FC; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Curtis JL; Pulmonary and Critical Care Medicine, VA Ann Arbor Healthcare System, Ann Arbor, Michigan.; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan., Martinez FJ; Pulmonary and Critical Care Medicine, Weill Cornell Medical College, New York, New York., Pasquale CB; COPD Patient-Powered Research Network, COPD Foundation, Washington, DC., Merrill DD; COPD Biomarkers Qualification Consortium, COPD Foundation, Miami, Florida., Metzdorf N; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Petruzzelli S; Global Clinical Development, Chiesi Farmaceutici, Parma, Italy., Tal-Singer R; COPD Biomarkers Qualification Consortium, COPD Foundation, Miami, Florida., Compton C; Global Medical Affairs, Speciality and Primary Care, GlaxoSmithKline, Middlesex, United Kingdom., Rennard S; Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; University of Nebraska Medical Center, Omaha, Nebraska; and., Martin UJ; Research and Development, AstraZeneca, Gaithersburg, Maryland.

Publikováno v: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Sep 01; Vol. 202 (5), pp. 660-671.

Diffusion capacity and static hyperinflation as markers of disease progression predict 3-year mortality in COPD: Results from COSYCONET.

Autor: Pott H; Department of Medicine, Pulmonary and Critical Care Medicine, Clinic for Airway Infections, University Medical Centre Marburg, Philipps-University Marburg, Marburg, Germany., Weckler B; Department of Medicine, Pulmonary and Critical Care Medicine, Clinic for Airway Infections, University Medical Centre Marburg, Philipps-University Marburg, Marburg, Germany., Gaffron S; Viscovery Gmbh, Vienna, Austria., Martin R; Heinrich Heine University Düsseldorf, Machine Learning for Medical Data, Institute for Computer Science, Düsseldorf, Germany., Maier D; Labvantage-Biomax GmbH, Munich, Germany., Alter P; Department of Medicine, Pulmonary and Critical Care Medicine, University of Marburg (UMR), Member of the German Centre for Lung Research [DZL], Marburg, Germany., Biertz F; CAPNETZ Foundation, Medical University Hannover, Hannover, Germany., Speicher T; Department of Medicine, Pulmonary and Critical Care Medicine, University of Marburg (UMR), Member of the German Centre for Lung Research [DZL], Marburg, Germany., Bertrams W; Institute for Lung Research, Universities of Giessen and Marburg Lung Centre, Philipps-University Marburg, Marburg, Germany., Jung AL; Institute for Lung Research, Universities of Giessen and Marburg Lung Centre, Philipps-University Marburg, Marburg, Germany.; German Center for Lung Research (DZL), Marburg, Germany., Laakmann K; Institute for Lung Research, Universities of Giessen and Marburg Lung Centre, Philipps-University Marburg, Marburg, Germany., Heider D; Institute for Medical Informatics, University of Münster, Münster, Germany., Wouters M; Maastricht University Medical Centre, Maastricht, the Netherlands and Sigmund Freud Private University, Vienna, Austria., Vogelmeier CF; Department of Medicine, Pulmonary and Critical Care Medicine, University of Marburg (UMR), Member of the German Centre for Lung Research [DZL], Marburg, Germany., Schmeck B; Department of Medicine, Pulmonary and Critical Care Medicine, Clinic for Airway Infections, University Medical Centre Marburg, Philipps-University Marburg, Marburg, Germany.; Institute for Lung Research, Universities of Giessen and Marburg Lung Centre, Philipps-University Marburg, Marburg, Germany.; Member of the German Centre for Lung Research (DZL) and German Centre of Infectious Disease Research, Marburg, Germany.

Publikováno v: Respirology (Carlton, Vic.) [Respirology] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.